Primary Myelofibrosis — Trials

Primary Myelofibrosis — Trials · CancerIndex

Clinical trials

Registered studies

242 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 30%
Top sponsor: City of Hope Medical Center
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 101–105 of 105 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569660	Ph II Study of Azacitidine in Myelofibrosis	completed	Phase 2	34	M.D. Anderson Cancer CenterOTHER	1	Aug 7, 2012	clinicaltrials
NCT00494585	CEP-701 for PH-negative Myelofibrosis	completed	Phase 2	27	M.D. Anderson Cancer CenterOTHER	1	Jun 25, 2012	clinicaltrials
NCT00719836